Halozyme Therapeutics Inc banner

Halozyme Therapeutics Inc
F:RV7

Watchlist Manager
Halozyme Therapeutics Inc Logo
Halozyme Therapeutics Inc
F:RV7
Watchlist
Price: 55.96 EUR 1.75% Market Closed
Market Cap: €7.1B

Dividends

Halozyme Therapeutics Inc
does not pay dividends

Shareholder Yield

Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Peers Comparison
Shareholder Yield

Buybacks

Buyback Yield
Halozyme Therapeutics Inc

Period
3Y
5Y
10Y
15Y
30Y
Buyback Yield, Past 5 Years
Min
Max
Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Peers Comparison
Buybacks

Debt Paydown

Debt Paydown Yield
Halozyme Therapeutics Inc

Period
3Y
5Y
10Y
15Y
30Y
Debt Paydown Yield, Past 5 Years
Min
Max
Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Peers Comparison
Debt Paydown

Price Appreciation

RV7 Price
Halozyme Therapeutics Inc

Annual Price Range
55.96
52w Low
42.45
52w High
68.68
Price Metrics
Average Annual Return 10.48%
Standard Deviation of Annual Returns 40.67%
Max Drawdown -51%
Shares Statistics
Market Capitalization 7.7B EUR
Shares Outstanding 127 186 000
Percentage of Shares Shorted
N/A

RV7 Return Decomposition
Main factors of price return

Stock Splits

No Stock Splits Found

We don't have any information about RV7's stock splits.

Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett